PE859
PE859 is a novel, orally active tau aggregation inhibitor that inhibits the heparin-induced aggregation of both 3RMBD and full length tau with IC50 of 0.81 uM and 2.23 uM, respectively; also inhibits amyloid β (Aβ) aggregation with IC50 of 1.2 uM; significantly reduces sarkosyl-insoluble aggregated tau along with the prevention of onset and progression of the motor dysfunction in JNPL3 P301L-mutated human tau transgenic mice.
Product Specifications
CAS Number
1402727-29-0
Product Name Alternative
PE-859 | PE 859
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 30 mg/mL
Smiles
COC1=CC (OCC2=NC=CC=C2) =CC=C1/C=C/C3=CC (/C=C/C4=CC5=C (C=C4) C=CN5) =NN3
Molecular Formula
C28H24N4O2
Molecular Weight
448.5157
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1H-Indole, 6-[ (1E) -2-[5-[ (1E) -2-[2-methoxy-4- (2-pyridinylmethoxy) phenyl]ethenyl]-1H-pyrazol-3-yl]ethenyl]-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Nostoc sp. UPF0296 protein asr0105 (asr0105)
Recombinant Nostoc sp. UPF0296 protein asr0105 (asr0105)
Recombinant Nostoc sp. UPF0296 protein asr0105 (asr0105)
Recombinant Nostoc sp. UPF0296 protein asr0105 (asr0105)
Recombinant Nostoc sp. UPF0296 protein asr0105 (asr0105)